X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-08-23 | MNMD | Gryska David W | Dir | P - Purchase | $5.98 | +3,500 | 17,351 | +25% | +$20,930 | ||||||
| M | 2024-08-19 | MNMD | Barrow Robert | CEO | P - Purchase | $6.22 | +1,000 | 565,543 | 0% | +$6,215 | |||||
2024-06-25 | MNMD | Karlin Dan | Chief Medical Officer | S - Sale | $7.22 | -6,925 | 351,527 | -2% | -$49,999 | ||||||
2024-06-25 | MNMD | Sullivan Mark | GC | S - Sale | $7.22 | -17,854 | 182,146 | -9% | -$128,906 | ||||||
2024-06-25 | MNMD | Barrow Robert | CEO | S - Sale | $7.22 | -15,659 | 564,543 | -3% | -$113,058 | ||||||
2024-03-25 | MNMD | Karlin Dan | Chief Medical Officer | S - Sale | $9.50 | -6,578 | 358,452 | -2% | -$62,491 | ||||||
2024-03-25 | MNMD | Barrow Robert | CEO | S - Sale | $9.50 | -16,519 | 580,202 | -3% | -$156,931 | ||||||
2023-12-26 | MNMD | Karlin Dan | Chief Medical Officer | S - Sale | $3.63 | -6,774 | 365,030 | -2% | -$24,590 | ||||||
2023-12-26 | MNMD | Barrow Robert | CEO | S - Sale | $3.63 | -13,237 | 596,721 | -2% | -$48,050 | ||||||
2023-12-26 | MNMD | Greenway Schond L. | CFO | S - Sale | $3.63 | -5,652 | 216,617 | -3% | -$20,517 | ||||||
2023-09-25 | MNMD | Barrow Robert | CEO | S - Sale | $3.58 | -13,499 | 611,729 | -2% | -$48,274 | ||||||
2023-09-25 | MNMD | Karlin Dan | Chief Medical Officer | S - Sale | $3.57 | -6,918 | 371,804 | -2% | -$24,730 | ||||||
2023-09-25 | MNMD | Greenway Schond L. | CFO | S - Sale | $3.58 | -5,762 | 222,269 | -3% | -$20,609 | ||||||
2023-08-25 | MNMD | Greenway Schond L. | CFO | S - Sale | $3.80 | -20,000 | 228,031 | -8% | -$76,000 | ||||||
2023-06-27 | MNMD | Barrow Robert | CEO | S - Sale | $3.20 | -15,502 | 623,457 | -2% | -$49,620 | ||||||
2023-06-27 | MNMD | Karlin Dan | Chief Medical Officer | S - Sale | $3.20 | -6,783 | 378,722 | -2% | -$21,697 | ||||||
2023-06-27 | MNMD | Greenway Schond L. | CFO | S - Sale | $3.20 | -11,635 | 248,031 | -4% | -$37,194 | ||||||
2023-03-01 | MNMD | Karlin Dan | Chief Medical Officer | S - Sale | $3.51 | -3,577 | 260,505 | -1% | -$12,555 | ||||||
2023-03-01 | MNMD | Barrow Robert | CEO | S - Sale | $3.51 | -8,273 | 238,959 | -3% | -$29,038 | ||||||
2022-12-21 | MNMD | Barrow Robert | CEO | S - Sale | $2.69 | -3,861 | 247,232 | -2% | -$10,386 | ||||||
2022-12-21 | MNMD | Karlin Dan | Chief Medical Officer | S - Sale | $2.69 | -1,211 | 264,082 | 0% | -$3,258 | ||||||
| M | 2022-10-25 | MNMD | Karlin Dan | Chief Medical Officer | S - Sale | $2.91 | -1,185 | 265,293 | 0% | -$3,452 | |||||
2022-10-25 | MNMD | Barrow Robert | CEO | S - Sale | $2.81 | -1,207 | 251,093 | 0% | -$3,392 | ||||||
2022-10-18 | MNMD | Barrow Robert | CEO | S - Sale | $3.11 | -1,220 | 252,300 | 0% | -$3,794 | ||||||
| M | 2022-09-26 | MNMD | Karlin Dan | Chief Medical Officer | S - Sale | $5.70 | -1,205 | 266,478 | 0% | -$6,870 | |||||
2022-09-26 | MNMD | Barrow Robert | CEO | S - Sale | $5.51 | -1,264 | 253,520 | 0% | -$6,965 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |